Search results for "Neurology"
MKSAP Quiz: difficult-to-treat migraine
A 30-year-old woman is evaluated for difficult-to-treat migraine. She has had severe headaches, usually on the first day of menses, since menarche. The pain is hemicranial, pulsatile, and associated with severe nausea and vomiting but no aura. She frequently awakens with the attack already in progress. A series of drug regimens have become ineffective in controlling pain. Following physical and neurological exams, what is the most appropriate next step in treatment?
https://immattersacp.org/weekly/archives/2016/09/20/3.htm
20 Sep 2016
Herpes zoster may be an independent risk factor for vascular disease
Herpes zoster was an independent risk factor for vascular disease, particularly in subjects affected before age 40, a study found.
https://immattersacp.org/weekly/archives/2014/01/14/4.htm
14 Jan 2014
Medical marijuana may help relieve some multiple sclerosis symptoms but has several safety concerns
Certain forms of medical marijuana can help treat some symptoms of multiple sclerosis (MS), but they do not appear to be helpful in treating drug-induced movements in Parkinson's disease, a review by the American Academy of Neurology found.
https://immattersacp.org/weekly/archives/2014/04/29/1.htm
29 Apr 2014
Some statins may offer protective effect for Parkinson's disease
Continued lipophilic statin therapy was associated with a decreased incidence of Parkinson's disease compared to starting and then stopping therapy, especially among female and elderly patients, a study found.
https://immattersacp.org/weekly/archives/2013/07/30/4.htm
30 Jul 2013
AHA/ASA releases updated guidelines for primary prevention of stroke
The American Heart Association/American Stroke Association last week released updated guidelines on the primary prevention of stroke that included new recommendations on the use of statins, blood pressure management, and risk stratification for atrial fibrillation.
https://immattersacp.org/weekly/archives/2014/11/04/4.htm
4 Nov 2014
COX-2 inhibitors associated with greater risk for death after ischemic stroke
Cyclooxygenase (COX)-2 inhibitor use before hospital admission for ischemic stroke was associated with a higher 30-day mortality rate, according to a new study.
https://immattersacp.org/weekly/archives/2014/11/11/4.htm
11 Nov 2014
MKSAP Quiz: episodic migraine during pregnancy
A 30-year-old woman is evaluated for episodic migraine without aura that first presented in high school and has persisted into the third trimester of her current pregnancy. The headache attacks occur two to four times monthly and last 12 to 24 hours. She experiences moderately severe pain, significant nausea, no vomiting, and pronounced photophobia with most of the attacks. Her only medication is prenatal vitamins. Physical examination findings, including vital signs, are normal. What is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2014/10/07/3.htm
7 Oct 2014
MKSAP Quiz: persistent right-sided facial weakness
A 53-year-old man is evaluated for persistent right-sided facial weakness. Three months ago, he first noticed “droopiness” of the right side of his lower face, difficulty closing the right eye and wrinkling the forehead, increased sensitivity to loud noises, and occasional slurred speech. Bell palsy was diagnosed, and he began a 10-day course of prednisone. He has noted only limited improvement, with continued facial drooping and mildly dysarthric speech; he now uses an eye patch over his right eye at night. Following a physical exam, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2015/12/15/3.htm
15 Dec 2015
MKSAP Quiz: recurrent visual disturbance, headache
BNP-guided therapy helps heart failure outcomes, no effect in hospitalizations
https://immattersacp.org/weekly/archives/2010/03/30/3.htm
30 Mar 2010
Vitamin D status associated with multiple sclerosis activity, progression
Higher vitamin D levels appear to be associated with reduced disease activity and a slower rate of disease progression in multiple sclerosis patients treated with interferon beta-1b, according to a study.
https://immattersacp.org/weekly/archives/2014/01/28/4.htm
28 Jan 2014